OptiScan Biomedical, a company based in Hayward, California, won FDA clearance to introduce its OptiScanner 5000 in the U.S. The device is intended for use in intensive care units to continuously monitor blood plasma glucose levels, something the OptiScanner 5000 can do accurately without having to be regularly calibrated. The device works via an (Read more...)